Clinical Trial Update: CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update describing results for Rituximab maintenance therapy in patients with chronic lymphocytic leukemia naive to chemotherapy (CHAIROS study) sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Rituximab (MabThera / Rituxan) (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2014-09-10